About Canbex Therapeutics
Canbex Therapeutics is a company based in London (United Kingdom) founded in 2005 was acquired by Ipsen in February 2015.. Canbex Therapeutics has raised $3.2 million across 1 funding round from investors including Merck and Ipsen. The company has 1 employees as of January 31, 2022. Canbex Therapeutics operates in a competitive market with competitors including Biogen, Denali Therapeutics, Annexon, Entrada Therapeutics and Adamas Pharma, among others.
- Headquarter London, United Kingdom
- Employees 1 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Canbex Therapeutics Limited
- Date of Incorporation 15 Mar, 2004
- Jurisdiction LONDON, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Canbex Therapeutics
Canbex Therapeutics has successfully raised a total of $3.2M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.2 million completed in April 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $3.2M
-
First Round
First Round
(08 Apr 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2013 | Amount | Series A - Canbex Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Canbex Therapeutics
Canbex Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Merck and Ipsen. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Merck is engaged in science and technology solutions globally.
|
Founded Year | Domain | Location | |
|
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Canbex Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Canbex Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Canbex Therapeutics Comparisons
Competitors of Canbex Therapeutics
Canbex Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, Denali Therapeutics, Annexon, Entrada Therapeutics and Adamas Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Biologics platform developed for intracellular delivery in rare diseases.
|
|
| domain | founded_year | HQ Location |
Pharmacokinetic profiles of approved drugs are enhanced for CNS therapeutics.
|
|
| domain | founded_year | HQ Location |
T-cell-based therapies for autoimmune and degenerative diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Canbex Therapeutics
When was Canbex Therapeutics founded?
Canbex Therapeutics was founded in 2005 and raised its 1st funding round 8 years after it was founded.
Where is Canbex Therapeutics located?
Canbex Therapeutics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is Canbex Therapeutics a funded company?
Canbex Therapeutics is a funded company, having raised a total of $3.2M across 1 funding round to date. The company's 1st funding round was a Series A of $3.2M, raised on Apr 08, 2013.
How many employees does Canbex Therapeutics have?
As of Jan 31, 2022, the latest employee count at Canbex Therapeutics is 1.
What does Canbex Therapeutics do?
Canbex Therapeutics was established in 2005 as a spin-out from University College London, based in London, United Kingdom. Proprietary VSN compound series small molecules are developed by the company for spasticity and other neurological disorders. The lead compound, VSN16R, an orally active agent, is undergoing phase 2 testing for spasticity relief in multiple sclerosis patients. An option agreement for acquisition by Ipsen was entered in February 2015.
Who are the top competitors of Canbex Therapeutics?
Canbex Therapeutics's top competitors include Alector, Intra-Cellular Therapies and Entrada Therapeutics.